Using mismatch on MRI to select thrombolytic responders: an attractive hypothesis awaiting confirmation

Stroke. 2005 May;36(5):1106-7. doi: 10.1161/01.STR.0000162390.53046.4b. Epub 2005 Mar 31.
No abstract available

Publication types

  • Comment

MeSH terms

  • Clinical Trials as Topic
  • Diffusion Magnetic Resonance Imaging*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Magnetic Resonance Angiography*
  • Patient Selection
  • Recombinant Proteins / therapeutic use
  • Stroke / diagnosis*
  • Stroke / drug therapy*
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator / genetics
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Tissue Plasminogen Activator